Sertraline Hcl Capsule
Product Images NDC 70377-129

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sertraline Hcl (NDC 70377-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sertraline-hcl-150mg-30s-label (Sertraline HCl 150mg 30s Label)

This text is a label for Sertraline Hydrochloride Capsules, with each capsule containing 168 mg of sertraline hydrochloride, equivalent to 150 mg of sertraline. The recommended dosage should be checked in the accompanying prescribing information. The capsules should be stored at 20°C to 25°C (68°F to 77°F), with permitted excursions to 15°C to 30°C (59°F to 86°F). The medication guide should be dispensed to each patient. The product is manufactured by Umedica Laboratories Pvt. Ltd. in India and distributed by Biocon Pharma Inc. in the USA.*

FDA Label Image

Sertraline-hcl-200mg-30s-label (Sertraline HCl 200mg 30s Label)

This is a description of Sertraline Hydrochloride Capsules with NDC 70377-129-11. Each capsule contains 224 mg of sertraline hydrochloride, equivalent to 200 mg of sertraline. The recommended dosage can be found in the accompanying prescribing information. It is advised to store the medication at 20°C to 25°C (68°F to 77°F). The medication is manufactured by Umedica Laboratories Pvt. Ltd. in Vapi, Gujarat, India, for Biocon Pharma Inc. in Iselin, New Jersey, USA. Patients should be dispensed with the Medication Guide with each purchase.*

FDA Label Image

Sertraline HCl (Sertraline HCl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.